MELD score is predictive of 90-day mortality after veno-arterial extracorporeal membrane oxygenation support
Karnib, Mohamad; Haraf, Rebecca; Tashtish, Nour; Zanath, Erica; Elshazly, Tarek; Garcia, Raul Angel; Billings, Scott; Fetros, Michael; Bradigan, Allison; Zacharias, Michael; Abu-Omar, Yasir; Elgudin, Yakov; Pelletier, Marc; Al-Kindi, Sadeer; Lytle, Francis; ElAmm, Chantal
BACKGROUND:The Model for End-Stage Liver Disease (MELD) score was originally described as a marker of survival in chronic liver disease. More recently, MELD and its derivatives, MELD excluding INR (MELD-XI) and MELD with sodium (MELD-Na), have been applied more broadly as outcome predictors in heart transplant, left ventricular assist device placement, heart failure, and cardiogenic shock, with additional promising data to support the use of these scores for prediction of survival in those undergoing veno-arterial extracorporeal membrane oxygenation (VA ECMO). METHODS:This study assessed the prognostic impact of MELD in patients with cardiogenic shock undergoing VA ECMO via a single-center retrospective review from January 2014 to March 2020. MELD, MELD-XI, and MELD-Na scores were calculated using laboratory values collected within 48 h of VA ECMO initiation. Multivariate Cox regression analyses determined the association between MELD scores and the primary outcome of 90-day mortality. Receiver operating characteristics (ROC) were used to estimate the discriminatory power for MELD in comparison with previously validated SAVE score. RESULTS:< 0.001). MELD-Na score and MELD-XI score were not associated with mortality. CONCLUSION/CONCLUSIONS:MELD score accurately predicts long-term mortality and may be utilized as a valuable decision-making tool in patients undergoing VA ECMO.
PMID: 34702105
ISSN: 1724-6040
CID: 5675522
Truth-telling and cancer diagnoses: physician attitudes and practices in Qatar
Rodriguez Del Pozo, Pablo; Fins, Joseph J; Helmy, Ismail; El Chaki, Rim; El Shazly, Tarek; Wafaradi, Deena; Mahfoud, Ziyad
There is limited information regarding physicians' attitudes toward revealing cancer diagnoses to patients in the Arab world. Using a questionnaire informed by a seminal study carried out by Oken in 1961, our research sought to determine present-day disclosure practices in Qatar, identify physician sociodemographic variables associated with truth-telling, and outline trends related to future practice. A sample of 131 physicians was polled. Although nearly 90% of doctors said they would inform cancer patients of their diagnosis, ∼66% of respondents stated that they made exceptions to their policy, depending on patient characteristics. These data suggest that clinical practices are somewhat discordant on professed beliefs about the ethical propriety of disclosure.
PMCID:3500369
PMID: 22874085
ISSN: 1549-490x
CID: 5675492